Open-label trial of anti-TNF-α in dermato- and polymyositis treated concomitantly with methotrexate

European Neurology

Volumn 59, Issue 3-4, 2008, Pages 159-163

  Hengstman, G J D ^a,b,c   De Bleecker, J L ^d   Feist, E ^e   Vissing, J ^f   Denton, C P ^h   Manoussakis, M N ⁱ   Slott Jensen, H ^g   Van Engelen, B G M ^a   Van Den Hoogen, F H J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MÁXIMA MEDICAL CENTER   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d Algemeen Ziekenhuis Sint Lucas Gent   (Belgium)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f Rigshospitalet   (Denmark)

^g GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^h ROYAL FREE HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Anti TNF therapy; Methotrexate; Myositis; Open label trial

Indexed keywords

CREATINE KINASE; FOLIC ACID; INFLIXIMAB; METHOTREXATE;

ADULT; ARTICLE; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DISEASE COURSE; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; DYNAMOMETRY; ENZYME BLOOD LEVEL; FEMALE; FEVER; HUMAN; IMMUNOTHERAPY; MALAISE; MULTICENTER STUDY; OPEN STUDY; POLYMYOSITIS; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 39749166410     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000114036     Document Type: Article

References (9)